143 related articles for article (PubMed ID: 17376054)
21. A study of the efficacy and safety of irbesartan in combination with conventional therapy, including ACE inhibitors, in heart failure. Irbesartan Heart Failure Group.
Tonkon M; Awan N; Niazi I; Hanley P; Baruch L; Wolf RA; Block AJ
Int J Clin Pract; 2000; 54(1):11-4, 16-8. PubMed ID: 10750252
[TBL] [Abstract][Full Text] [Related]
22. The effect of hyperbaric oxygen therapy on tumour growth in a mouse model of colorectal cancer liver metastases.
Daruwalla J; Christophi C
Eur J Cancer; 2006 Dec; 42(18):3304-11. PubMed ID: 17010602
[TBL] [Abstract][Full Text] [Related]
23. Losartan versus captopril in elderly patients with heart failure.
Ball SG
Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164338
[No Abstract] [Full Text] [Related]
24. Losartan versus captopril in elderly patients with heart failure.
Sechi LA; Catena C; Bartoli E
Lancet; 1997 May; 349(9063):1474; author reply 1475. PubMed ID: 9164337
[No Abstract] [Full Text] [Related]
25. Losartan versus captopril in elderly patients with heart failure.
Jensen BV; Nielsen SL
Lancet; 1997 May; 349(9063):1473; author reply 1475. PubMed ID: 9164335
[No Abstract] [Full Text] [Related]
26. Effect of thalidomide on colorectal cancer liver metastases in CBA mice.
Daruwalla J; Nikfarjam M; Malcontenti-Wilson C; Muralidharan V; Christophi C
J Surg Oncol; 2005 Aug; 91(2):134-40. PubMed ID: 16028287
[TBL] [Abstract][Full Text] [Related]
27. [ACE inhibitors or AT1 receptor antagonists?].
Riegger GA
Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S37-9. PubMed ID: 10535045
[No Abstract] [Full Text] [Related]
28. Effect of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on the frequency of post-cardiothoracic surgery atrial fibrillation.
Coleman CI; Makanji S; Kluger J; White CM
Ann Pharmacother; 2007 Mar; 41(3):433-7. PubMed ID: 17341525
[TBL] [Abstract][Full Text] [Related]
29. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Toblli JE; Muñoz MC; Cao G; Mella J; Pereyra L; Mastai R
Obesity (Silver Spring); 2008 Apr; 16(4):770-6. PubMed ID: 18239590
[TBL] [Abstract][Full Text] [Related]
30. [Review of randomized trials of angiotensin receptor blockers in the treatment of patients with congestive heart failure].
Rakugi H; Ogihara T
Nihon Rinsho; 2001 Oct; 59(10):2051-61. PubMed ID: 11676153
[TBL] [Abstract][Full Text] [Related]
31. [Evidence for the benefits of ACE inhibitors and AII antagonists in slowing progressive renal failure in diabetes].
Suzuki H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():323-8. PubMed ID: 12430248
[No Abstract] [Full Text] [Related]
32. Comparison of angiotensin-converting enzyme inhibitor alone and in combination with irbesartan for the treatment of heart failure.
Kum LC; Yip GW; Lee PW; Lam YY; Wu EB; Chan AK; Fung JW; Chan JY; Zhang Q; Kong SL; Yu CM
Int J Cardiol; 2008 Mar; 125(1):16-21. PubMed ID: 17433840
[TBL] [Abstract][Full Text] [Related]
33. The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder.
Porter AJ; Pillidge K; Grabowska EM; Stanford SC
Eur Neuropsychopharmacol; 2015 Apr; 25(4):512-21. PubMed ID: 25703442
[TBL] [Abstract][Full Text] [Related]
34. Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model.
Malcontenti-Wilson C; Chan L; Nikfarjam M; Muralidharan V; Christophi C
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e96-e104. PubMed ID: 17559382
[TBL] [Abstract][Full Text] [Related]
35. Effects of angiotensin-converting enzyme inhibitor plus irbesartan on maximal and submaximal exercise capacity and neurohumoral activation in patients with congestive heart failure.
Blanchet M; Sheppard R; Racine N; Ducharme A; Curnier D; Tardif JC; Sirois P; Lamoureux MC; De Champlain J; White M
Am Heart J; 2005 May; 149(5):938.e1-7. PubMed ID: 15894946
[TBL] [Abstract][Full Text] [Related]
36. Effect of angiotensin receptor blockade on central haemodynamics in essential hypertension: results of a randomised trial.
Schneider MP; Delles C; Klingbeil AU; Ludwig M; Kolloch RE; Krekler M; Stumpe KO; Schmieder RE
J Renin Angiotensin Aldosterone Syst; 2008 Mar; 9(1):49-56. PubMed ID: 18404609
[TBL] [Abstract][Full Text] [Related]
37. [Effects of combination therapy with angiotensin I-converting enzyme inhibitor and angiotensin 1 receptor antagonist on ventricular remodeling and expression of endothelial nitric oxide synthase].
Zhang RY; Huang YL; Sun YH
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1053-6. PubMed ID: 16029550
[TBL] [Abstract][Full Text] [Related]
38. [When after myocardial infarction a pump weakness remains. ACE inhibitors and AT-1 blockers equivalent].
MMW Fortschr Med; 2003 Dec; 145(49):18-9. PubMed ID: 14963986
[No Abstract] [Full Text] [Related]
39. Renal vascular responses to captopril and to candesartan in patients with type 1 diabetes mellitus.
Lansang MC; Price DA; Laffel LM; Osei SY; Fisher ND; Erani D; Hollenberg NK
Kidney Int; 2001 Apr; 59(4):1432-8. PubMed ID: 11260405
[TBL] [Abstract][Full Text] [Related]
40. Comparative effects of AT1-antagonism and angiotensin-converting enzyme inhibition on markers of inflammation and platelet aggregation in patients with coronary artery disease.
Schieffer B; Bünte C; Witte J; Hoeper K; Böger RH; Schwedhelm E; Drexler H
J Am Coll Cardiol; 2004 Jul; 44(2):362-8. PubMed ID: 15261932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
